188 related articles for article (PubMed ID: 7040440)
1. Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.
Mshana RN; Haregewoin A; Belehu A
J Clin Immunol; 1982 Apr; 2(2):69-74. PubMed ID: 7040440
[TBL] [Abstract][Full Text] [Related]
2. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
Garraud O; Ribierre O; Bach MA
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
[TBL] [Abstract][Full Text] [Related]
3. Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies.
Mshana RN; Haregewoin A; Harboe M; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):291-6. PubMed ID: 6216220
[TBL] [Abstract][Full Text] [Related]
4. Thymus-dependent lymphocytes of peripheral blood in leprosy patients.
Lim SD; Kiszkiss DF; Jacobson RR; Choi YS; Good RA
Infect Immun; 1974 Feb; 9(2):394-9. PubMed ID: 4544619
[TBL] [Abstract][Full Text] [Related]
5. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
[TBL] [Abstract][Full Text] [Related]
7. Leprosy XII. Quantitative analysis of thymus-derived lymphocyte response to phytohemagglutinin in leprosy.
Lim SD; Jacobson RR; Park BH; Good RA
Int J Lepr Other Mycobact Dis; 1975; 43(2):95-100. PubMed ID: 1081499
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of T-cell unresponsiveness in leprosy.
Bach MA; Hoffenbach A; Lagrange PH; Wallach D; Cottenot F
Ann Immunol (Paris); 1983; 134D(1):75-84. PubMed ID: 6226239
[TBL] [Abstract][Full Text] [Related]
9. Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.
Laal S; Bhutani LK; Nath I
Infect Immun; 1985 Dec; 50(3):887-92. PubMed ID: 2933339
[TBL] [Abstract][Full Text] [Related]
10. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
11. Lepromin-induced suppressor cells in lepromatous leprosy.
Nelson EE; Wong L; Uyemura K; Rea TH; Modlin RL
Cell Immunol; 1987 Jan; 104(1):99-104. PubMed ID: 2948676
[TBL] [Abstract][Full Text] [Related]
12. [Histoid leprosy with erythema nodosum leprosum].
Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
Job CK; Jacobson RR; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
[TBL] [Abstract][Full Text] [Related]
14. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.
Modlin RL; Bakke AC; Vaccaro SA; Horwitz DA; Taylor CR; Rea TH
Arch Dermatol; 1985 Feb; 121(2):216-9. PubMed ID: 3156560
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission.
Miller RA; Shen JY; Rea TH; Harnisch JP
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):441-9. PubMed ID: 3309088
[TBL] [Abstract][Full Text] [Related]
16. A Case of Lepromatous Leprosy With Erythema Nodosum Leprosum.
Park L; Wallace CE; Vasile G; Buckley C
Cureus; 2023 Jan; 15(1):e33846. PubMed ID: 36819324
[TBL] [Abstract][Full Text] [Related]
17. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient.
Suryawati N; Saputra H
Int J Mycobacteriol; 2018; 7(2):191-194. PubMed ID: 29900900
[TBL] [Abstract][Full Text] [Related]
18. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
[TBL] [Abstract][Full Text] [Related]
19. Concanavalin A induced suppressor activity in human leprosy.
Nath I; Narayanan RB; Mehra NK; Sharma AK; Gupte MD
J Clin Lab Immunol; 1979 Nov; 2(4):319-24. PubMed ID: 161322
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide--effect on T cell subsets as a possible mechanism of action.
Moncada B; Baranda ML; González-Amaro R; Urbina R; Loredo CE
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
